Hybrid Conferencee

International Conference on Neuropharmacology and Therapeutic Advances (ICNPTA - 26)

5th - 6th August 2026 | San Pedro Sula, Honduras

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in San Pedro Sula. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the San Pedro Sula event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the San Pedro Sula conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in San Pedro Sula, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in San Pedro Sula."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
Track 01

Advancements in Neuropharmacology

This track will explore the latest breakthroughs in neuropharmacology, focusing on novel drug formulations and their mechanisms of action. Researchers are invited to present their findings on innovative therapeutic agents targeting neurological disorders.

Track 02

Neuroprotective Agents: Mechanisms and Applications

This session will delve into the mechanisms by which neuroprotective agents exert their effects on neuronal health. Contributions that discuss both preclinical and clinical applications of these agents in various brain disorders are encouraged.

Track 03

Neurotransmission and Pharmacological Interventions

This track aims to investigate the intricate processes of neurotransmission and how pharmacological interventions can modulate these pathways. Presentations should focus on the implications of these interventions for treating neurological conditions.

Track 04

Clinical Trials in Neurotherapeutics

This session will highlight the design, implementation, and outcomes of clinical trials focused on neurotherapeutics. Researchers are invited to share their experiences and insights regarding the challenges and successes in this field.

Track 05

Pharmacotherapy for Neurodegenerative Diseases

This track will address the current state of pharmacotherapy for neurodegenerative diseases, including Alzheimer's and Parkinson's disease. Discussions will focus on emerging therapies and their potential to alter disease progression.

Track 06

Innovations in Drug Development for Brain Disorders

This session will showcase innovative approaches in drug development specifically aimed at treating brain disorders. Contributions should emphasize novel methodologies and technologies that enhance therapeutic efficacy.

Track 07

Neurotransmitter Systems and Their Role in Mental Health

This track will explore the role of various neurotransmitter systems in mental health and disease. Presenters are encouraged to discuss pharmacological strategies that target these systems for therapeutic benefit.

Track 08

Emerging Neurotherapeutics: Challenges and Opportunities

This session will focus on the emerging landscape of neurotherapeutics, discussing both the challenges faced in development and the opportunities for innovation. Contributions that highlight case studies or novel approaches are particularly welcome.

Track 09

Drug Mechanisms in Neurological Disorders

This track will investigate the mechanisms of action of drugs used in the treatment of neurological disorders. Researchers are invited to present their findings on how these mechanisms can inform better therapeutic strategies.

Track 10

Translational Research in Neuropharmacology

This session will emphasize the importance of translational research in bridging laboratory findings with clinical applications in neuropharmacology. Presentations should focus on successful case studies that illustrate this translation.

Track 11

Future Directions in Neuropharmacology Research

This track will provide a platform for discussing future directions and emerging trends in neuropharmacology research. Participants are encouraged to share visionary ideas that could shape the future of therapeutic interventions in neuroscience.